{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T19:08:15Z","timestamp":1759777695860,"version":"3.41.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2015,6,24]],"date-time":"2015-06-24T00:00:00Z","timestamp":1435104000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00210-015-1146-x","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T06:40:34Z","timestamp":1435041634000},"page":"1105-1112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of new class III antiarrhythmic drug niferidil on electrical activity in murine ventricular myocardium and their ionic mechanisms"],"prefix":"10.1007","volume":"388","author":[{"given":"Denis V.","family":"Abramochkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vladislav S.","family":"Kuzmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonid V.","family":"Rosenshtraukh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,24]]},"reference":[{"key":"1146_CR1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1113\/jphysiol.2004.063446","volume":"559","author":"J Brouillette","year":"2004","unstructured":"Brouillette J, Clark RB, Giles WR, Fiset C (2004) Functional properties of K+ currents in adult mouse ventricular myocytes. J Physiol 559:777\u2013798","journal-title":"J Physiol"},{"key":"1146_CR2","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","volume":"33","author":"AJ Camm","year":"2012","unstructured":"Camm AJ, Lip GYH, Caterina R, Savelieva I, et al (2012) ESC Committee for Practice Guidelines (CPG). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation. Eur Heart J 33:2719\u20132747","journal-title":"Eur Heart J"},{"key":"1146_CR3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00005344-200007000-00011","volume":"36","author":"VV Fedorov","year":"2000","unstructured":"Fedorov VV, Sharifov OF, Beloshapko GG, Yushmanova AV, Rosenshtraukh LV (2000) Effects of a new class III antiarrhythmic drug nibentan in a canine model of vagally mediated atrial fibrillation. J Cardiovasc Pharmacol 36:77\u201389","journal-title":"J Cardiovasc Pharmacol"},{"key":"1146_CR4","first-page":"66","volume":"44","author":"VV Fedorov","year":"2004","unstructured":"Fedorov VV, Rosenshtraukh LV, Reznik AV, et al (2004) Antiarrhythmic efficacy of a new class III antiarrhythmic drug RG-2. Kardiologiia 44:66\u201374","journal-title":"Kardiologiia"},{"key":"1146_CR5","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2146\/ajhp080501","volume":"67","author":"M Finnin","year":"2010","unstructured":"Finnin M (2010) Vernakalant: a novel agent for the termination of atrial fibrillation. Am J Health Syst Pharm 67:1157\u20131164","journal-title":"Am J Health Syst Pharm"},{"key":"1146_CR6","first-page":"3","volume":"45","author":"RG Glushkov","year":"2011","unstructured":"Glushkov RG, Yuzhakov SD, L\u2019vov AI, et al (2011) New group of class III antiarrhythmic drugs: piperid-4-ylethane derivatives. Pharm Chem J 45:3\u201312","journal-title":"Pharm Chem J"},{"key":"1146_CR7","first-page":"A10356","volume":"124","author":"SP Golitsyn","year":"2011","unstructured":"Golitsyn SP, Yuricheva YA, Maykov EB, et al (2011) Intravenous niferidil, a new class III antiarrhythmic agent, for termination of persistent atrial fibrillation and flutter. Circulation 124:A10356 Abstract","journal-title":"Circulation"},{"key":"1146_CR8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00021.2009","volume":"90","author":"H Hibino","year":"2010","unstructured":"Hibino H, Inanobe A, Furutani K, Murakami S, Findlay I, Kurachi Y (2010) Inwardly rectifying potassium channels: their structure, function, and physiological roles. Physiol Rev 90:291\u2013366","journal-title":"Physiol Rev"},{"key":"1146_CR9","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF00584963","volume":"395","author":"G Isenberg","year":"1982","unstructured":"Isenberg G, Klockner U (1982) Calcium tolerant ventricular myocytes prepared by preincubation in a \u2018KB-medium\u2019. Pflugers Arch 395:6\u201318","journal-title":"Pflugers Arch"},{"key":"1146_CR10","first-page":"87","volume":"349","author":"U Jahnel","year":"1994","unstructured":"Jahnel U, Klemm P, Nawrath H (1994) Different mechanisms of the inhibition of the transient outward current in rat ventricular myocytes. Naunyn Schmiedeberg's Arch Pharmacol 349:87\u201394","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"1146_CR11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0008-6363(00)00208-X","volume":"48","author":"A Kamkin","year":"2000","unstructured":"Kamkin A, Kiseleva I, Isenberg G (2000) Stretch-activated currents in ventricular myocytes: amplitude and arrhythmogenic effects increase with hypertrophy. Cardiovasc Res 48:409\u2013420","journal-title":"Cardiovasc Res"},{"key":"1146_CR12","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/01.RES.78.4.689","volume":"78","author":"GR Li","year":"1996","unstructured":"Li GR, Feng J, Yue L, Carrier M, Nattel S (1996) Evidence for two components of delayed rectifier K+ current in human ventricular myocytes. Circ Res 78:689\u2013696","journal-title":"Circ Res"},{"key":"1146_CR13","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00424-007-0436-7","volume":"456","author":"GX Liu","year":"2008","unstructured":"Liu GX, Zhou J, Koren G (2008) Single-channel properties of IK,slow1 and IK,slow2 in mouse ventricular myocytes. Pflugers Arch - Eur J Physiol 456:541\u2013547","journal-title":"Pflugers Arch - Eur J Physiol"},{"key":"1146_CR14","first-page":"27","volume":"3","author":"MD Mashkovsky","year":"1995","unstructured":"Mashkovsky MD, Glushkov RG, Dorodnikova SD, et al (1995) The search for antiarrhythmic drug among the derivatives of 1,5-diaminopentane. Khim Farm Zh 3:27\u201331","journal-title":"Khim Farm Zh"},{"key":"1146_CR15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/FJC.0000000000000112","volume":"64","author":"EB Maykov","year":"2014","unstructured":"Maykov EB, Yuricheva YA, Mironov NY, et al (2014) Efficacy of a new class III drug niferidil in cardioversion of persistent atrial fibrillation and flutter. J Cardiovasc Pharmacol 64:247\u2013255","journal-title":"J Cardiovasc Pharmacol"},{"key":"1146_CR16","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000016318","volume":"9","author":"S Nattel","year":"1999","unstructured":"Nattel S, Yue L, Wang Z (1999) Cardiac ultrarapid delayed rectifiers: a novel potassium current family of functional similarity and molecular diversity. Cell Physiol Biochem 9:217\u2013226","journal-title":"Cell Physiol Biochem"},{"key":"1146_CR17","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1124\/jpet.107.127654","volume":"324","author":"CP Regan","year":"2008","unstructured":"Regan CP, Kiss L, Stump GL, et al (2008) Atrial antifibrillatory effects of structurally distinct IKur blockers 3-[(dimethylamino)methyl]-6-methoxy-2-methyl-4-phenylisoquinolin-1(2\u00a0H)-one and 2-phenyl-1,1-dipyridin-3-yl-2-pyrrolidin-1-yl-ethanol in dogs with underlying heart failure. J Pharmacol Exp Ther 324:322\u2013330","journal-title":"J Pharmacol Exp Ther"},{"key":"1146_CR18","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.ehj.2004.04.030","volume":"25","author":"J Reisinger","year":"2004","unstructured":"Reisinger J, Gatterer E, Lang W, et al (2004) Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset. Eur Heart J 25:1318\u20131324","journal-title":"Eur Heart J"},{"key":"1146_CR19","first-page":"76","volume":"43","author":"AV Reznik","year":"2003","unstructured":"Reznik AV, Fedorov VV, Kokoz YM, et al (2003) Ionic mechanisms of cardiotropic action of a new class III antiarrhythmic drug RG-2. Kardiologiia 43:76\u201382","journal-title":"Kardiologiia"},{"key":"1146_CR20","first-page":"56","volume":"43","author":"LV Rosenshtraukh","year":"2003","unstructured":"Rosenshtraukh LV, Fedorov VV, Reznik AV, et al (2003) Electrophysiological experimental study of a novel class III antiarrhythmic drug RG-2. Kardiologiia 43:56\u201363","journal-title":"Kardiologiia"},{"key":"1146_CR21","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/sj.bjp.0707403","volume":"152","author":"A Sridhar","year":"2007","unstructured":"Sridhar A, da Cunha DN, Lacombe VA, et al (2007) The plateau outward current in canine ventricle, sensitive to 4-aminopyridine, is a constitutive contributor to ventricular repolarization. Br J Pharmacol 152:870\u2013879","journal-title":"Br J Pharmacol"},{"key":"1146_CR22","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1085\/jgp.113.5.661","volume":"113","author":"H Xu","year":"1999","unstructured":"Xu H, Guo W, Nerbonne JM (1999) Four kinetically distinct depolarization-activated K+ currents in adult mouse ventricular myocytes. J Gen Physiol 113:661\u2013677","journal-title":"J Gen Physiol"},{"key":"1146_CR23","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0022-3565(24)36723-0","volume":"281","author":"X Zhang","year":"1997","unstructured":"Zhang X, Anderson JW, Fedida D (1997) Characterization of nifedipine block of the human heart delayed rectifier, hKv1.5. J Pharmacol Exp Ther 281:1247\u20131256","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-015-1146-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-015-1146-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-015-1146-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T20:20:41Z","timestamp":1748463641000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-015-1146-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,24]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1146"],"URL":"https:\/\/doi.org\/10.1007\/s00210-015-1146-x","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"type":"print","value":"0028-1298"},{"type":"electronic","value":"1432-1912"}],"subject":[],"published":{"date-parts":[[2015,6,24]]}}}